InvestorsHub Logo
Followers 16
Posts 772
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Thursday, 11/17/2022 10:48:04 AM

Thursday, November 17, 2022 10:48:04 AM

Post# of 198380
Read it and REAP! Hahahahah this investing game is so easy. Thank you Charles!

Charles Cotropia, the Company CEO, said: “The breadth of patent coverage that is sought and expected is extremely far-reaching based on the discovery of the critical target epitope sites necessary to effectively neutralize these viruses. The Company has also identified conserved epitopes using its AI platform on multiple other viruses, including HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV) and Visna virus (VISNA). These findings will also be protected by patent coverage.”

https://enzolytics.com/company-news/